Cargando…

A network-based approach reveals long non-coding RNAs associated with disease activity in lupus nephritis: key pathways for flare and potential biomarkers to be used as liquid biopsies

OBJECTIVE: A blood-based biomarker is needed to assess lupus nephritis (LN) disease activity, minimizing the need for invasive kidney biopsies. Long non-coding RNAs (lncRNAs) are known to regulate gene expression, appear to be stable in human plasma, and can serve as non-invasive biomarkers. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sentis, George, Loukogiannaki, Catherine, Malissovas, Nikos, Nikolopoulos, Dionysis, Manolakou, Theodora, Flouda, Sofia, Grigoriou, Maria, Banos, Aggelos, Boumpas, Dimitrios T., Filia, Anastasia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355154/ https://www.ncbi.nlm.nih.gov/pubmed/37475860 http://dx.doi.org/10.3389/fimmu.2023.1203848

Ejemplares similares

Combined – whole blood and skin fibroblasts- transcriptomic analysis in Psoriatic Arthritis reveals molecular signatures of activity, resistance and early response to treatment
por: Grivas, Alexandros, et al.
Publicado: (2022)

Cross-species transcriptome analysis for early detection and specific therapeutic targeting of human lupus nephritis
por: Frangou, Eleni, et al.
Publicado: (2022)

Patrolling human SLE haematopoietic progenitors demonstrate enhanced extramedullary colonisation; implications for peripheral tissue injury
por: Kokkinopoulos, Ioannis, et al.
Publicado: (2021)

ATR-mediated DNA damage responses underlie aberrant B cell activity in systemic lupus erythematosus
por: Manolakou, Theodora, et al.
Publicado: (2022)

Microglia activation in the presence of intact blood–brain barrier and disruption of hippocampal neurogenesis via IL-6 and IL-18 mediate early diffuse neuropsychiatric lupus
por: Nikolopoulos, Dionysis, et al.
Publicado: (2023)

Transcriptome reprogramming and myeloid skewing in haematopoietic stem and progenitor cells in systemic lupus erythematosus
por: Grigoriou, Maria, et al.
Publicado: (2020)

Transition to severe phenotype in systemic lupus erythematosus initially presenting with non-severe disease: implications for the management of early disease
por: Nikolopoulos, Dionysis S, et al.
Publicado: (2020)

Flares in Lupus Nephritis: Risk Factors and Strategies for Their Prevention
por: Banos, Aggelos, et al.
Publicado: (2023)

Restoration of aberrant gene expression of monocytes in systemic lupus erythematosus via a combined transcriptome-reversal and network-based drug repurposing strategy
por: Nikolakis, Dimitrios, et al.
Publicado: (2023)

Mitophagy Balance in Various Cell Subsets in Patients with ANCA-Associated Vasculitis and Correlation with the Presence of Anti-Neutrophil Cytoplasmic Antibodies
por: Banos, Aggelos, et al.
Publicado: (2020)

The genomic landscape of ANCA-associated vasculitis: Distinct transcriptional signatures, molecular endotypes and comparison with systemic lupus erythematosus
por: Banos, Aggelos, et al.
Publicado: (2023)

Antiviral Innate Immune Responses in Autoimmunity: Receptors, Pathways, and Therapeutic Targeting
por: Stergioti, Eirini Maria, et al.
Publicado: (2022)

Value of repeat biopsy in lupus nephritis flares
por: Greloni, G, et al.
Publicado: (2014)

The value of repeat biopsy in lupus nephritis flares
por: Narváez, Javier, et al.
Publicado: (2017)

Cerebrovascular Events in Systemic Lupus Erythematosus: Diagnosis and Management
por: Nikolopoulos, Dionysis, et al.
Publicado: (2019)

Evolving phenotype of systemic lupus erythematosus in Caucasians: low incidence of lupus nephritis, high burden of neuropsychiatric disease and increased rates of late-onset lupus in the ‘Attikon’ cohort
por: Nikolopoulos, D, et al.
Publicado: (2020)

Molecular Taxonomy of Systemic Lupus Erythematosus Through Data-Driven Patient Stratification: Molecular Endotypes and Cluster-Tailored Drugs
por: Garantziotis, Panagiotis, et al.
Publicado: (2022)

DNA Damage Response in the Adaptive Arm of the Immune System: Implications for Autoimmunity
por: Manolakou, Theodora, et al.
Publicado: (2021)

Lupus nephritis flare in young patients: relapse or nonadherence to treatment?
por: Rivera, Francisco, et al.
Publicado: (2014)

Demyelinating Syndromes in Systemic Lupus Erythematosus: Data From the “Attikon” Lupus Cohort
por: Nikolopoulos, Dionysis, et al.
Publicado: (2022)

Characterising the immune profile of the kidney biopsy at lupus nephritis flare differentiates early treatment responders from non-responders
por: Parikh, Samir V, et al.
Publicado: (2015)

The cost of flares among patients with systemic lupus erythematosus with and without lupus nephritis in the United States
por: Bell, Christopher F, et al.
Publicado: (2022)

Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus
por: Adamichou, Christina, et al.
Publicado: (2021)

The Influence of an Elastase-Sensitive Complement C5 Variant on Lupus Nephritis and Its Flare
por: Toy, Chris R., et al.
Publicado: (2021)

Renal flare as a biomarker of incident and progressive chronic kidney disease in patients with lupus nephritis
por: Parikh, S, et al.
Publicado: (2012)

Role of early repeated renal biopsies in lupus nephritis
por: Zickert, A, et al.
Publicado: (2014)

Clinicopathological Correlation in Asian Patients with Biopsy-Proven Lupus Nephritis
por: Satirapoj, Bancha, et al.
Publicado: (2015)

Do we still need renal biopsy in lupus nephritis?
por: Haładyj, Ewa, et al.
Publicado: (2016)

Mast cells in the kidney biopsies of pediatric patients with lupus nephritis
por: Santos, Stéfany Silva, et al.
Publicado: (2020)

Early achievement of deep remission predicts low incidence of renal flare in lupus nephritis class III or IV
por: Hanaoka, Hironari, et al.
Publicado: (2018)

WCN23-0359 RENAL FLARE IN ADOLESCENTS WITH LUPUS NEPHRITIS RECEIVED COVID-19 mRNA VACCINE
por: THEPVEERA, S., et al.
Publicado: (2023)

Development of an ANCA-Associated Vasculitides Patient Registry in Greece
por: Thomas, Konstantinos, et al.
Publicado: (2020)

Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study
por: Nikoloudaki, Myrto, et al.
Publicado: (2023)

Janus kinase inhibitors in systemic lupus erythematosus: implications for tyrosine kinase 2 inhibition
por: Nikolopoulos, Dionysis, et al.
Publicado: (2023)

Lupus Enteritis: An Uncommon Presentation of Lupus Flare
por: Potera, Joanna, et al.
Publicado: (2021)

Causes and predictors of mortality in biopsy-proven lupus nephritis: the Sarawak experience
por: Teh, Cheng Lay, et al.
Publicado: (2018)

Value of monitoring urine ammonia at time of biopsy in patients with lupus nephritis
por: Zhu, Huanhuan, et al.
Publicado: (2020)

Treat-to-Target in Lupus Nephritis. What is the Role of the Repeat Kidney Biopsy?
por: Parodis, Ioannis, et al.
Publicado: (2022)

Revisiting Vasculopathy in Lupus Nephritis: A Renal Biopsy Evaluation Study
por: Lakshmi, V Ramya, et al.
Publicado: (2022)

Kidney Biopsy in Pregnant Women with Glomerular Diseases: Focus on Lupus Nephritis
por: Moroni, Gabriella, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1006ku94sjrp1240v9p6bf8s5t